{"id":10449,"date":"2017-04-21T00:00:00","date_gmt":"2017-04-20T22:00:00","guid":{"rendered":"https:\/\/idibell.cat\/es\/blog\/2017\/04\/21\/investigadores-del-idibell-buscan-nuevos-farmacos-contra-el-melanoma\/"},"modified":"2021-07-28T15:07:14","modified_gmt":"2021-07-28T13:07:14","slug":"investigadores-del-idibell-buscan-nuevos-farmacos-contra-el-melanoma","status":"publish","type":"post","link":"https:\/\/idibell.cat\/es\/2017\/04\/investigadores-del-idibell-buscan-nuevos-farmacos-contra-el-melanoma\/","title":{"rendered":"Investigadores del IDIBELL buscan nuevos f\u00e1rmacos contra el melanoma"},"content":{"rendered":"

Investigadores del Instituto de Investigaci\u00f3n Biom\u00e9dica de Bellvitge (IDIBELL) y del Instituto de Investigaciones Biom\u00e9dicas August Pi i Sunyer (IDIBAPS) han participado en el trabajo publicado recientemente en la revista Journal Investigative Dermatology, que lleva por t\u00edtulo \u00abAURORA A overexpression (Aurken) is driven by FOXM1 and MAPK \/ ERK activaci\u00f3n in melanoma cells harbouring BRAF oro NRAS Mutations: Impact on melanoma prognosis and therapy \u00ab.
\nLos autores describen que la sobreexpresi\u00f3n de AURKA (Aurora Kinasa A, prote\u00edna implicada en el control del ciclo celular), se asocia a un peor pron\u00f3stico en los enfermos de melanoma cut\u00e1neo. La expresi\u00f3n de esta prote\u00edna depende de factores de transcripci\u00f3n como FOXM1 y de la activaci\u00f3n de las v\u00edas de se\u00f1alizaci\u00f3n MAPK-ERK, a menudo debida a la presencia de mutaciones NRAS o BRAF. Sin embargo, la inhibici\u00f3n farmacol\u00f3gica o el silenciamiento de AURKA y FOXM1 afecta a la proliferaci\u00f3n y supervivencia de las c\u00e9lulas de melanoma, incluso aquellas resistentes a los inhibidores de BRAF. Los excelentes resultados en estudios pre-cl\u00ednicos sugieren que el uso de inhibidores de Aurken y FOXM1 puede beneficiar a los pacientes de melanoma resistentes a las terapias anti-BRAF y \/ o en portadores de mutaciones NRAS, hasta ahora hu\u00e9rfanos de terapias adecuadas .
\nPor parte del IDIBELL, han participado los Dres JR Ferreres y J Marcoval del Servicio de Dermatolog\u00eda del Hospital Universitario de Bellvitge; y los Dres MA Pujana, JM Piulats, L Palomero, F Mateo del ICO-IDIBELL y tambi\u00e9n E Cabr\u00e9, A Vinyals liderados por la Dra \u00c0 Fabra del Laboratorio de Oncolog\u00eda Molecular-IDIBELL.
\nEl trabajo ha sido financiado con el apoyo de: \u00abFundaci\u00f3n La Marat\u00f3 de TV3\u00bb; la \u00abAsociaci\u00f3n Espa\u00f1ola contra el C\u00e1ncer (AECC)\u00bb; el \u00abAGAUR\u00bb; \u00abRTICC\u00bb; \u00abISCIII\u00bb y \u00abFondos FEDER\u00bb.<\/b><\/b><\/b><\/p>\n","protected":false},"excerpt":{"rendered":"

Investigadores del Instituto de Investigaci\u00f3n Biom\u00e9dica de Bellvitge (IDIBELL) y del Instituto de Investigaciones Biom\u00e9dicas August Pi i Sunyer (IDIBAPS) han participado en el trabajo publicado recientemente en la revista Journal Investigative Dermatology, que lleva por t\u00edtulo \u00abAURORA A overexpression (Aurken) is driven by FOXM1 and MAPK \/ ERK activaci\u00f3n in melanoma cells harbouring BRAF […]<\/p>\n","protected":false},"author":6,"featured_media":10450,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[184,292,281,247],"tags":[],"publishpress_future_action":{"enabled":false,"date":"2024-05-10 01:51:43","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/10449"}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=10449"}],"version-history":[{"count":1,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/10449\/revisions"}],"predecessor-version":[{"id":18025,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/10449\/revisions\/18025"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media\/10450"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=10449"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/categories?post=10449"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/tags?post=10449"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}